Arg-ADNI. Gustavo E. Sevlever, Silvia Vázquez, Deborah R. Gustafson, Salvador M. Guinjoan, Ricardo F. Allegri(*) and Arg-ADNI group.

Similar documents
Arg-ADNI. WW-ADNI update, Boston, July 12, 2013

AAIC Satellite Symposium: Buenos Aires, Argentina April 17-18, 2018 Sheraton Libertador Hotel Grand Bourg Ballroom

Introduction. Keywords Activities of daily living Aging Alzheimer s disease Cognitive disorders Mild cognitive impairment

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing

Early Diagnosis of Alzheimer s Disease and MCI via Imaging and Pattern Analysis Methods. Christos Davatzikos, Ph.D.

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease

Argentina-Alzheimer s disease neuroimaging initiative (Arg-ADNI): neuropsychological evolution profile after one-year follow up

Anosognosia, or loss of insight into one s cognitive

2013 AAIC WW-ADNI Meeting, Boston K-ADNI Update

MRI Hippocampal Volume for Enrichment

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

Response Ratio Female % Male % No Response(s) 1 <1 % Totals %

Implementation of fully automated immunoassays for CSF Aβ 1-42, t-tau and p-tau 181 in the Alzheimer s Disease Neuroimaging Initiative

Il processo diagnostico dell Alzheimer dalla clinica al neuroimaging Giovanni B. Frisoni M.D.

Form D1: Clinician Diagnosis

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Tammie Benzinger, MD, PhD

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Is PET/CT really helpful in diagnosing Alzheimer s Disease?

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease

Advances in Alzheimer s diagnosis; implications for clinical practice. Wiesje M. van der Flier Alzheimer Europe Conference Berlin, 4 October 2017

Mild Cognitive Impairment (MCI)

Alzheimer's Disease An update on diagnostic criteria & Neuropsychiatric symptoms. l The diagnosis of AD l Neuropsychiatric symptoms l Place of the ICT

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing

Stephen Salloway, M.D., M.S. Disclosure of Interest

Mild Cognitive Impairment Symposium January 19 and 20, 2013

Brain imaging for the diagnosis of people with suspected dementia

Assessing and Managing the Patient with Cognitive Decline

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

Background. In discussions of recruitment, the question was raised as to whether returning research results to subjects would help recruitment.

Neuroinflammation in preclinical AD: in vivo evidence

Pocket Reference to Alzheimer s Disease Management

Roche satellite symposium/educational session CTAD Asia - China Conference Transforming AD in China: From Diagnosis to Treatment

Disclosure Statement

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

Mild Cognitive Impairment

Defeating dementia: progress and challenges on the road to 2025

Molecular Imaging Heterogeneity of Clinically Defined AD

#CHAIR2015. Miami, Florida. September 24 26, JW Marriott Miami. Sponsored by

European Prevention of Alzheimer s Dementia (EPAD)

CAMD Annual Regulatory Science Workshop CSF Biomarker Team Refocusing on Low Hanging Fruit

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities

BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer s disease presented at AAIC 2018

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation

Alzheimer s Disease Neuroimaging Initiative

Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos,

Dementia, Cognitive Aging Services and Support

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

AT RISK, SCI, EMCI: THE ALPHABET SOUP OF PRECLINICAL AND PRODROMAL ALZHEIMER DISEASE

CSF Aβ1-42 predicts cognitive impairment in de novo PD patients

Part 2: Early detection, assessment and treatment in relation to the new guidelines. Christopher Patterson McMaster University

Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy

The Aging Brain The Aging Brain

Changing diagnostic criteria for AD - Impact on Clinical trials

How can the new diagnostic criteria improve patient selection for DM therapy trials

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association

On cognitive performance as endpoint in clinical trials Ben Schmand

U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

Regulatory Challenges across Dementia Subtypes European View

4/28/2017. Aging with Down Syndrome. Second Annual USC UCEDD Community Education Conference May 19, 2017

Gerardo Machnicki 1, Ricardo F. Allegri 1,2 *, Carol Dillon 1, Cecilia M. Serrano 1,2 and Fernando E Taragano 2 SUMMARY INTRODUCTION

Early Onset Dementia From the background to the foreground

Sandra Weintraub, PhD Clinical Core Leader and Professor

Flicker Light-Induced Retinal Vasodilation is Lower in Alzheimer s Disease

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease

SUPPLEMENTARY INFORMATION In format provided by Frank et al. (JULY 2010)

2005 Annual Report of the Center for Alzheimer s Care, Imaging & Research Department of Neurology. Center for Alzheimer s Care, Imaging and Research

Cognitive Aging: Defining normal vs. disease?

review of existing studies on ASL in dementia Marion Smits, MD PhD

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Dementia mimicking Alzheimer s disease Owing to a tau mutation: CSF and PET findings

Supplementary Online Content

Alzheimer s Biomarkers Consortium of Down Syndrome (ABC-DS)

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

La demenza si può predire, prevenire e quindi trattare

INI. Therapeutic Effects of Intranasally-Administered Insulin (INI) for amci or Mild AD. Study of Nasal Insulin to Fight Forgetfulness (AKA)

ALZHEIMER'S DISEASE PREVENTION TRIALS

Evaluations. Alzheimer s Disease A Public Health Response. Viewer Call-In. July 19, Guest Speakers. Thanks to our Sponsors:

Secondary prevention of Alzheimer s dementia: neuroimaging contributions

arxiv: v1 [stat.ml] 21 Sep 2017

ADNI PET CORE. Vancouver BC April Susan Landau, Andy Horng, Suzanne Baker, Bob Koeppe, Eric Reiman, Kewei Chen, Chet Mathis, Julie Price

Outline. Facts and figures Action plans Early / correct diagnosis Conclusions

XIV Anual Scientific Meeting I International Meeting Argentine Society of Lipids - International Atherosclerosis Society

Imaging of Alzheimer s Disease: State of the Art

Indiana University School of Medicine, Indianapolis, IN USA 1

Raymond Y. Lo, MD, MS William J. Jagust, MD For the Alzheimer s Disease Neuroimaging Initiative

FOR IMMEDIATE RELEASE July 26, 2018 Eisai Co., Ltd. Biogen Inc.

SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Clinical Genetics & Dementia

ADNI PET CORE. Boston April Bill Jagust, Suzanne Baker, Bob Koeppe, Eric Reiman, Kewei Chen, Chet Mathis, Julie Price

New Research on Neuraceq TM (florbetaben F18 injection) Imaging to be Presented at Annual Alzheimer s Association International Conference

New diagnostic criteria for Alzheimer s disease and mild cognitive impairment for the practical neurologist

Carol Manning, PhD, ABPP-CN Director, Memory Disorders Clinic University of Virginia

Diagnosis and Treatment of Alzhiemer s Disease

Neuroimaging for dementia diagnosis. Guidance from the London Dementia Clinical Network

Transcription:

Arg-ADNI Gustavo E. Sevlever, Silvia Vázquez, Deborah R. Gustafson, Salvador M. Guinjoan, Ricardo F. Allegri(*) and Arg-ADNI group. Memory and Aging Center Institute for Neurological Research (FLENI) Buenos Aires, Argentina *speaker WW-ADNI update: Copenhagen, July 11, 2014

Argentine ADNI 2011-2014 1. Background 2. Work-Plan 3. Results 4. AAIC and other meetings 5. Publications 6. New Projects

Worldwide Life Expectancy 78a 62a 70a 81a 79a 79a 75a 74a Argentina 76a 72a 68a 73a 81a 76a Buenos Aires 78a 78a 77a 76a Font: CIA World Factbook / INDEC

Argentina

Institute for Neurological Research Memory and Aging Center Institute for Neurological Research FLENI Buenos Aires Argentina Institute for Neurological Rehabilitation www.fleni.org.ar/alzheimer

Argentine ADNI 2011-2014 1. Background 2. Work-Plan 3. Results 4. AAIC and other meetings 5. Publications 6. New Projects

Arg-ADNI 1 st Arg-ADNI: FLENI Cohort (2011-2014) Single-Center, Pilot Study-60pts Main Project 2 nd Arg-ADNI: Multicenter Cohort (2015-2018)

Arg-ADNI Management Committee Sevlever G, Allegri RF, Guinjoan S, Gustafson D, Vazquez S. Clinical Stream Neurologists Ricardo Allegri (*) Jorge Campos Alejandra Amengual Gabriela Cohen Neuroimaging Stream Silvia Vazquez S (*) Esteban Obenaus German Falasco Leandro Urrutia Fernando Ventrice Laboratory Stream Gustavo Sevlever (*) Horacio Martinetto Ezequiel Surace Miguel Riudavetz Epidemiological Stream Deb Gustafson (*) Marcos Fernández Suárez Patricio Chrem Julieta Russo Psychiatrists Salvador Guinjoan Griselda Russo Pablo Bagnati Lucas Drucaroff Neuropsychologists Liliana Sabe María Eugenia Martín Florencia Clarens Lucía Crivelli Paula Harris (*) Stream Chair

Arg-ADNI 1 st Cohort (FLENI) Study Timelines 11/20/2013 Last patient / first visit 1 06/08/2014 Copenhagen Study report 2 01/19/2012 First patient / first visit 02/10/2011 FLENI Review Board approval 1. Recruitment: 24 months 2. Follow-up: 24 months

Patients Invited to ADNI Nº= 73 Arg-ADNI 1st Cohort (FLENI) Patients Flowchart Patients Screened at FLENI Nº= 60 Screening Failure Nº= 7 2 Claustrophobia 1 Psychiatric Disease 1 Cancer 1 Adult ADHD 2 without informant Patients Followed (1 st year) Nº= 50 Dropout Nº= 3 2 removed inform.cons 1 by distance/caregiver Healthy Controls Nº= 10 Early MCI Nº=15 Late MCI Nº= 16 Dementia AD Nº=9

Arg-ADNI 1 st Cohort (FLENI) Table 1: Demographic Data Healthy Controls Early MCI Late MCI Dementia AD 10 15 16 9 Age (years) 68 70 75 75 Education (years) 14 12.9 13.6 12.1 Sex (%fem) 70% 40% 68.8% 44.4% MMSE 30 28.9 27.1 21.4

Arg-ADNI 1 st Cohort (FLENI) Methods: ADNI 1. Demographic and Neurological Exams 2. Neuropsychological Assessment 3. Cognitive Reserve Inventory 4. Blood sampling including DNA banking 5. Cerebro Spinal Fluid (AB42, tau and f-tau) 6. MRI (3.0T) 7. FDG PET-CT scan 8. 11 C-PiB PET-CT scan

Argentine ADNI 2011-2014 1. Background 2. Work-Plan 3. Results 4. AAIC and other meetings 5. Publications 6. New Projects

Arg-ADNI 1 st Cohort (FLENI) Results Baseline Follow-up Follow-up Total Nº NPS Ass MRI CSF Aβ-tau PET FDG PET PiB Follow-up 1 year Healthy Controls 10 10 10 7 10 9 6 Follow-up 2 year Early MCI 15 15 15 12 15 12 8 Late MCI 16 16 16 11 15 13 7 Dementia AD 9 9 9 8 9 9 2 TOTAL 50 50 50 38 (76%) 49 (98%) 43 (86%) 23

Brain 18 FDG PET scan Brain 11 C-PiB PET scan Uptake Map AD Healthy Hypometabolism Map AD

Arg-ADNI 1 st Cohort (FLENI) Results Table 3: PET Scanning as of June 2014 FDG-PET Normal FDG-PET Pathol PiB-PET Negative PiB-PET Possitive Healthy Control s 5 5 10 0 Early MCI 2 9 5 3 Late MCI 3 11 4 8 Dementia AD 0 9 1 8 Total 10 34 20 19

Brain Bank. FLENI houses the only brain bank in Argentina. ADNI participants are being asked to consent brain donation at the time of death. Brain banking: opportunities, challenges and meaning for the future Hans Kretzschmar Nature Reviews Neuroscience 10, 70-78 (January 2009)

Argentine ADNI 2011-2014 1. Background 2. Work-Plan 3. Results 4. AAIC and other meetings 5. Publications 6. New Projects

April 2014

POSTER in AAIC>14 Alzheimer s Imaging Consortium (AIC) pre-conference 1. Discrepancy between PiB amyloid imaging in typical and atypical clinical diagnosis. (nº: IC-P-005) 2. Hippocampal atrophy. Automated volumetry vs visual examination: Arg-ADNI cohort analysis (nº: IC-P-006)

Argentine ADNI 2011-2014 1. Background 2. Work-Plan 3. Results 4. AAIC and other meetings 5. Publications 6. New Projects

Papers submitted 1. Concordance between C 11 -PiB amyloid imaging and clinical diagnosis in a memory clinic. American Journal of Alzheimer s Disease and other Dementias. 2. Discriminability and Response bias Indices in recognition memory performance in amnestic mild cognitive impairment and Alzheimer s disease. Alzheimer & Dementia 3. Hippocampal atrophy. Automated volumetry vs visual examination: an ARG ADNI cohort analysis

Argentine ADNI 2011-2014 1. Background 2. Work-Plan 3. Results 4. AAIC and other meetings 5. Publications 6. New Projects

Future Tasks Arg-DIAN (Dominantly Inherited Alzheimer Network) National grant application (CONICET) June 2014 to study an Argentine DIAN cohort of 40 participant. Start-up October 2014

Future Tasks Arg-ADNI 2 nd Cohort (Argentine Multicenter Study) National grant application (2015-2018) to study larger Argentina ADNI 2 cohort of 180pts involving at least 8 new sites (AD Centers). Mendoza 9.-Univ. Mendoza Mar del Plata 7.- CEMA Córdoba 8.- Instituto Neuropsiquiátrico Kremer Buenos Aires 1.- FLENI 2.- Hospital Zubizarreta (GCBA) 3.- INEBA 4.- Hospital Fernandez (GCBA) 5.- Hospital Borda (GCBA) La Plata 6.- Instituto Neuropsiquiátrico Luria

Thank you ADNI Argentina